BEIJING, Dec. 11, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, announced today that…
Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England’s National…
Genflow to Attend the 44th Annual J.P. Morgan Healthcare Conference LONDON, UK / ACCESS Newswire / December 11, 2025 /…
New AI models integrating imaging, clinical, and molecular data from the TAILORx tissue biorepository show stronger prognostic performance than current…
Calgary, Alberta--(Newsfile Corp. - December 10, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"),…
Reinforcing its commitment to rare disease treatment access, Sentynl is transitioning its program to myTomorrows patient-centric platform. AMSTERDAM, Dec. 10, 2025…
Connected Brand Identity Simplifies Access to Innovative, Agile Solutions that Drive Momentum for Companies in the Health and Life Science…
ATLANTA, Dec. 10, 2025 /PRNewswire/ -- Veritiv Operating Company, a leader in specialty packaging distribution, facility solutions and print products and…
Giredestrant is the only oral SERD to show superior invasive disease-free survival in the adjuvant setting, marking the first significant…
Giredestrant is the only oral SERD to show superior invasive disease-free survival in the adjuvant setting, marking the first significant…